Hot Features
Premium
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Zeitraum:
Zeichenmodus:
| Volumen | 0 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Ambrx Biopharma Inc | AMAM | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 28,00 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 28,00 | 28,00 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 6,55 - 28,15 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | US$ 28,00 | USD |
Finanzwerte AMAM
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| US$ 1,75B | - | - | - | 66,67 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Ambrx Biopharma
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 18.3.2024 | 19:45 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section.. |
| 12.3.2024 | 21:55 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11.3.2024 | 05:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 08.3.2024 | 19:39 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in.. |
| 07.3.2024 | 19:23 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
| 07.3.2024 | 14:49 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.3.2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 23.2.2024 | 20:09 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 22.2.2024 | 14:31 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 22.2.2024 | 14:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12.2.2024 | 19:43 | PR Newswire (US) | Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to.. |
| 10.1.2024 | 21:07 | PR Newswire (US) | Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to.. |
Forum Ambrx Biopharma
Keine Diskussionen Gefunden.Neuen Thread Erstellen
AMAM Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Monate | 27,78 | 28,03 | 27,51 | 27,89 | 1.516.369 | 0,22 | 0,79% |
| 6 Monate | 9,91 | 28,15 | 7,99 | 22,68 | 1.567.548 | 18,09 | 182,54% |
| 1 Jahr | 9,65 | 28,15 | 6,55 | 18,80 | 1.016.346 | 18,35 | 190,16% |
| 3 Jahre | 10,74 | 28,15 | 6,55 | 18,22 | 953.178 | 17,26 | 160,71% |
| 5 Jahre | 10,74 | 28,15 | 6,55 | 18,22 | 953.178 | 17,26 | 160,71% |
